Revolution Medicines, Inc. SEC Filing
Revolution Medicines insider sale reported.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Revolution Medicines insider sale reported. The filing lists sales by Jack Anders of 3,104 shares on 12/16/2025 and 10,000 shares on 01/07/2026, with reported proceeds of $239,288.60 and $980,000.00 respectively.
The notice also lists historical restricted stock unit grants with grant dates of 03/01/2022, 09/01/2022, 03/01/2023, 03/01/2024, and 03/01/2025, showing grant quantities of 261, 225, 597, 593, and 458 shares.
Insights
Form 144 lists routine Rule 144 sales by a reporting person with prior RSU grants disclosed.
The filing records two open-market dispositions by Jack Anders: $239,288.60 for 3,104 shares on 12/16/2025 and $980,000.00 for 10,000 shares on 01/07/2026. The notice also documents prior restricted stock unit grants across 2022–2025.
These filings are administrative notices required when restricted securities are sold under Rule 144; the listed grant dates and share amounts provide context about the source of the shares. Subsequent filings would show any further sales or changes in reported holdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.